title: Cell-cell and cell-matrix dynamics in intraperitoneal cancer metastasis.
abstract: The peritoneal metastatic route of cancer dissemination is shared by cancers of the ovary and gastrointestinal tract. Once initiated, peritoneal metastasis typically proceeds rapidly in a feed-forward manner. Several factors contribute to this efficient progression. In peritoneal metastasis, cancer cells exfoliate into the peritoneal fluid and spread locally, transported by peritoneal fluid. Inflammatory cytokines released by tumor and immune cells compromise the protective, anti-adhesive mesothelial cell layer that lines the peritoneal cavity, exposing the underlying extracellular matrix to which cancer cells readily attach. The peritoneum is further rendered receptive to metastatic implantation and growth by myofibroblastic cell behaviors also stimulated by inflammatory cytokines. Individual cancer cells suspended in peritoneal fluid can aggregate to form multicellular spheroids. This cellular arrangement imparts resistance to anoikis, apoptosis, and chemotherapeutics. Emerging evidence indicates that compact spheroid formation is preferentially accomplished by cancer cells with high invasive capacity and contractile behaviors. This review focuses on the pathological alterations to the peritoneum and the properties of cancer cells that in combination drive peritoneal metastasis.
authors.affiliation: Department of Cell and Systems Biology, University of Toronto, Toronto, ON, Canada.
authors.forename: Katharine L
authors.initials: KL
authors.lastname: Sodek
authors.forename: K Joan
authors.initials: KJ
authors.lastname: Murphy
authors.forename: Theodore J
authors.initials: TJ
authors.lastname: Brown
authors.forename: Maurice J
authors.initials: MJ
authors.lastname: Ringuette
mesh_terms: D000205:Actomyosin / Q000037:antagonists & inhibitors / Q000378:metabolism; D000818:Animals; D000970:Antineoplastic Agents / Q000494:pharmacology / Q000627:therapeutic use; D001201:Ascites; D002448:Cell Adhesion; D002470:Cell Survival; D019008:Drug Resistance, Neoplasm; D005109:Extracellular Matrix / Q000378:metabolism*; D006801:Humans; D007249:Inflammation / Q000378:metabolism; D058628:Myofibroblasts / Q000378:metabolism; D009361:Neoplasm Invasiveness; D009362:Neoplasm Metastasis; D009369:Neoplasms / Q000188:drug therapy / Q000378:metabolism / Q000473:pathology; D010534:Peritoneal Neoplasms / Q000378:metabolism* / Q000556:secondary*; D010537:Peritoneum / Q000378:metabolism / Q000473:pathology; D059748:Proteolysis
chemical_list: D000970:Antineoplastic Agents; D000205:Actomyosin